Valve stress echocardiography (VSE) is increasingly used both within specialist valve clinics and within dedicated VSE services, mandating practical guidance for referral, procedure, reporting, and clinical implementation of results. Therefore, a didactic VSE guide was compiled based on current European Society of Cardiology and American College of Cardiology/American Heart Association valve disease management guidelines, review of existing evidence, and the authors' extensive experience with VSE. The VSE indications were grouped into 3 categories: symptoms despite nonsevere valve disease, asymptomatic severe valve disease, and valve disease with reduced left ventricular systolic function.
I
n patients who have asymptomatic severe valve disease, exercise testing is an established practice to detect occult symptoms (1) (2) (3) (4) (5) . However, additional diagnostic and prognostic information can be obtained by adding echocardiographic imaging to exercise testing or to dobutamine infusion, in a wider range of indications (1) (2) (3) 6) . Valve stress echocardiography (VSE) is being increasingly used, both within the specialist valve clinics and within dedicated VSE services receiving referrals from cardiologists and cardiac surgeons outside the boundaries of the specialist valve clinic. To aid in this evolving clinical practice, and mirroring routine in the authors' own departments, the current paper presents a didactic guide for VSE procedures and reporting and also for VSE referral and interpretation of results; the information is based on guidelines, recommendations, referenced current evidence, and the authors' experience. The HAVEC (Heart Valve Clinic International Database) group recognized the need for concerted efforts to enhance the VSE evidence base before the update of current valve disease management guidelines to reflect expert practice trends.
REFERRAL GUIDE
The VSE indications can be classified into 3 categories: symptoms despite nonsevere valve disease, asymptomatic severe valve disease, and valve disease with reduced left ventricular (LV) systolic function.
Throughout the text, the references associated with each indication denote whether the indication is well established and generally accepted, being consequently included in current European Society of Cardiology (ESC) and American College of Cardiology (ACC)/American Heart Association (AHA) guidelines (1, 2) and recommendations (7), or is not well established but supported by some more recent evidence.
Comments lacking a reference represent the opinion of the authors. The VSE indications' acceptance status and evidence have been summarized (Table 1) to highlight the gap between current trends and guidelines. The goal of the test depends on the VSE indication ( Table 2) .
SYMPTOMS DESPITE NONSEVERE VALVE DISEASE.
Exertional breathlessness, chest pain, or unexplained acute pulmonary edema requires revaluation of valve disease severity based on flow-dependent changes or on its dynamic component (1, 2) .
Mitral regurgitation. Secondary mitral regurgitation (MR) as a result of ischemic heart disease is likely to worsen on exertion, but this outcome can occur for any MR etiology (1, 2, 8, 9) . In patients with unexplained acute pulmonary edema (1, 8) , stress may induce myocardial ischemia with associated dynamic ischemic MR.
Mild MR is an indication for exercise VSE before coronary artery bypass grafting (CABG), as suggested by evidence from the RIME (Randomized Ischemic Mitral Evaluation) trial (10) . This trial found that mitral annuloplasty at the time of CABG in patients with moderate ischemic MR at rest or developed on exertion might improve functional capacity, LV reverse remodeling, MR severity, and B-type natriuretic peptide levels. The ESC guidelines (1) recommend mitral valve surgery at the time of CABG in patients with moderate MR and use of VSE to assess symptoms and exertion-induced MR severity and systolic pulmonary arterial pressure (SPAP) increases.
Mitral stenosis. A noncompliant mitral valve may be moderately stenotic at rest but hemodynamically severely stenotic during stress, as it fails to open further to accommodate the increase in flow (1, 2, 6, (11) (12) (13) (14) (15) . In addition, because indexed valve area thresholds are not defined, VSE may be useful for grading mitral stenosis (MS) in patients with a large body surface area (13) . Gradient thresholds (1, 2, 11, (16) (17) (18) (19) Aortic regurgitation. Aortic regurgitation (AR) is reduced at high heart rates as diastole shortens even if the systemic pressure rises. Consequently, although exercise testing is recommended to confirm equivocal symptoms (2), echocardiographic imaging can only be added with the goal of revealing inducible myocardial ischemia but not with the goal of re-grading AR severity.
Aortic stenosis. As with MS, a noncompliant aortic valve may be moderately stenotic at rest but severely stenotic during stress (20, 21) because the valve fails to open further.
Consequently, gradient increase and calculated functional valve area failure to increase during VSE suggest severe aortic stenosis (AS) (5, 8, 11, 13, 20, 21) . VSE is indicated (1,2) to regrade AS severity in symptomatic patients.
Furthermore, because coexistence of coronary artery disease is common in calcific AS, the VSE may also detect inducible ischemia. Prosthetic valves. A VSE is recommended to help diagnose an obstructive prosthetic valve (7) . A significant mean gradient rise (for both aortic and mitral prosthetic valves) (16, 24) and a calculated functional valve area failure to rise (for aortic prosthetic valves) Valve Stress Echocardiography with associated reproduction of symptoms during VSE suggest that an obstructive valve is the cause of symptoms (patient-prosthesis mismatch or prosthesis stenosis). A mean gradient rise is significant if it is at least >20 mm Hg for prosthetic aortic valves and at least >12 mm Hg for prosthetic mitral valves (11) . In cases of an obstructive prosthetic aortic valve, the VSE may also reveal inducible ischemia or significant exertion-induced MR (7) . In cases of an obstructive prosthetic mitral valve, the VSE may also reveal an exertion-induced SPAP increase to >60 mm Hg. ASYMPTOMATIC SIGNIFICANT VALVE DISEASE. The main goal of VSE is to detect occult symptoms because they are an indication for surgery, as with spontaneously reported symptoms (1, 2 Severe AR. Exercise testing is indicated to uncover symptoms (2) because of the high mortality implied.
Exercise VSE allows for assessment of LV contractile reserve, the lack of which predicts the development of LV systolic dysfunction at follow-up or postoperatively (8, 29) . Longitudinal function at rest and on exertion may also aid in the detection of early LV systolic dysfunction (8, 30 
PROCEDURE GUIDE
There is limited information in the published data regarding practical aspects of the VSE procedure.
Therefore, this procedure guide is mainly based on the experience of the authors.
TYPE OF STRESS.
Depending on clinical indication, the VSE is performed with exercise or dobutamine ( active patients with incidental low-flow, low-gradient AS, might potentially achieve the target workload (20% increase in LVOT-derived stroke volume), which allows for a correct diagnosis (8, 20, 23, (38) (39) (40) (41) (42) (43) (44) ).
An exertion-induced increase in stroke volume, demonstrating the existence of flow reserve with an associated rise in calculated functional AV area, suggests target workload and test endpoint achievement.
It is the opinion of the current writing group that a dobutamine test can be avoided in this case. However, if the achieved workload is low, with an apparent lack of flow reserve, the test should be repeated with dobutamine. workload is more specific for a pathological response. Regarding sequence of events, whereas low LV systolic function at peak (or post-peak) exercise may signify a lack of contractile reserve, an
Garbi et al.
Valve Stress Echocardiography initial increase in LV systolic function at low workload followed by a drop at high workload suggests the existence of inducible ischemia rather than a lack of contractile reserve (45). Treadmill exercise excludes image acquisition at low workload, when contractility recruitment is achieved but the heart rate remains below forbidden levels (100 to 110 beats/min) for some modalities (i.e., 3-dimensional echocardiography for LV contractile reserve). Garbi et al.
The sequence of image acquisition for a minimum dataset according to VSE indication is displayed in To allow LV systolic function assessment, either with 3-dimensional LVEF or speckle tracking-derived global longitudinal strain, low workload images should be acquired at a heart rate <100 to 110 beats/ min. The higher the heart rate, the higher the optimal frame rate (or volume rate) for image acquisition.
Optimization is obtained by reducing the depth of acquisition to include the LV only, minimizing the sector width, and, for 3-dimensional imaging, using multicycle acquisition.
A suboptimal frame rate can also limit the quality of color flow Doppler images; therefore, a narrow sector and lower possible depth acquisition is recommended with zoom images being used for measurements (e.g., proximal isovelocity surface area Tables 1 and 2 . 
REPORTING GUIDE
In the absence of relative information in the existing published data, the reporting guide describes the clinical practice of the authors. A nonprescriptive guide of minimum information to be included in the report according to VSE indication is provided in Table 5 .
The exercise VSE report includes information regarding achieved workload as an absolute value and as a percentage of the maximum predicted workload.
The exercise tolerance of the patient is graded considering not only the achieved workload but also the usual level of activity (sedentary patients are The dobutamine VSE report includes information regarding dose and duration of dobutamine infusion, developed symptoms, potential complications (e.g., arrhythmia, vaso-vagal), and the reason for termination of the test.
The description of findings is difficult to standardize, and the characterization of disease is challenging, particularly in cases of >1 valve disease. In self-declared "asymptomatic" patients, the observed symptomatic status is reported. In self-declared "symptomatic" patients, the relationship of symptoms with the observed VSE-induced changes is reported, stating whether it is believed that the symptoms are due to the valve disease. Grading of valve disease severity based on VSE findings is also reported.
CLINICAL IMPLEMENTATION OF RESULTS
Clinical management is tailored according to VSEdiagnosed valve disease severity and symptomatic status, as described in Table 6 In the authors' clinical practice, however, a lack of LV contractile reserve triggers a case discussion by the heart valve team, taking into consideration the suitability of valve morphology for repair, surgical risk, local repair success rate, and surgical mortality rate.
Wait times for intervention are also considered because of the high probability of hemodynamic decompensation within 6 months (26, 27) . In unexplained pulmonary edema, only the ESC guidelines (1) recommend VSE. Despite the lack of evidence, this seems a reasonable VSE indication (8) to exclude ischemia and ischemic MR. Nevertheless, evidence is needed regarding the incidence of VSEdemonstrated MR (or other hemodynamic changes) in this setting.
Before CABG, only the ESC guidelines (1) recommend MR assessment with VSE to inform decisionmaking regarding concomitant mitral valve repair.
As described earlier in the Mitral Regurgitation section, the RIME trial (10) provides evidence on this topic. This trial reported mitral valve repair benefit at the time of CABG in patients with at least moderate MR at rest or on exertion but did not specifically address the role of VSE. For this assessment, a similar study would be needed, randomizing patients with at least moderate MR on exertion only.
In AR, the ACC/AHA guidelines (2) recommend exercise testing. There is no role for echocardiography to regrade AR severity during exertion, because, as described in the Aortic Regurgitation section, AR is reduced with increases in heart rate.
ASYMPTOMATIC SIGNIFICANT VALVE DISEASE.
Both the ESC and the ACC/AHA valve disease management guidelines ( (27) . The role of 3-dimensional echocardiography must also be investigated, considering its higher accuracy and reproducibility in LVEF assessments.
In AS, both guidelines (1,2) also recommend intervention in cases of blood pressure drop on exertion.
Nevertheless, only the ESC guidelines recommend intervention (Class IIb) in cases of mean gradient rise >20 mm Hg during VSE. There is evidence (36, 37) that this mean gradient rise confers poor prognosis within 18 to 24 months, although clinical follow-up of patients with severe AS is performed at shorter intervals. Because samples used in the aforementioned studies were small, further evidence is needed.
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